Acne Vulgaris

Type: Keyphrase
Name: Acne Vulgaris
First reported 15 hours ago - Updated 5 hours ago - 1 reports

Free medication samples in dermatology offices appear to change prescribing practices for acne

The availability of free medication samples in dermatology offices appears to change prescribing practices for acne , a common condition for which free samples are often available.Free drug samples provided by pharmaceutical companies are widely available ... [Published News-Medical.Net - 15 hours ago]
First reported Apr 07 2014 - Updated Apr 07 2014 - 2 reports

Chromogenex Announces Third Generation Body Shaping System

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact ... [Published GTN News - Apr 07 2014]
First reported Apr 01 2014 - Updated Apr 01 2014 - 1 reports

The effects of oral isotretinoin (13-Cis retinoic acid) on the inner ear: A prospective clinical study

Mehmet Akdag, Zeynep M Akkurt, Aylin Gul, Derya Ucmak, Beyhan Yılmaz, Engin Sengul, Ismail TopcuAbstractPurpose: The purpose of this study was to investigate the effect of oral isotretinoin, a drug used in the treatment of acne vulgaris, on hearing function ... [Published Clinical & Investigative Medicine - Apr 01 2014]
First reported Mar 28 2014 - Updated Mar 28 2014 - 1 reports

Novan Announces Positive Phase 2 Results for Novel Acne Treatment

Novan Therapeutics, a specialty pharmaceutical company focused on medical nitric oxide therapies has announced positive Phase 2 study results of its topical SB204 drug candidate for the treatment of acne vulgaris. The Phase 2 study was a double blind, ... [Published MedEsthetics Magazine - Mar 28 2014]
First reported Mar 27 2014 - Updated Mar 27 2014 - 1 reports

GLENMARK PHARMACEUTICALS : Patent Issued for Stable Fixed Dose Topical Formulation

By a News Reporter-Staff News Editor at Pharma Business Week -- Glenmark Pharmaceuticals Limited ( Mumbai , IN) has been issued patent number 8673356, according to news reporting originating out of Alexandria, Virginia , by NewsRx editors (see also Glenmark ... [Published 4 Traders - Mar 27 2014]
First reported Mar 24 2014 - Updated Mar 24 2014 - 2 reports

Novan Therapeutics announces positive results from Phase II acne vulgaris study

Novan Therapeutics, Inc., a specialty pharmaceutical company, has announced positive Phase II study results of its topical SB204 drug candidate for the treatment of acne vulgaris. The Phase II study was a double blind, vehicle-controlled, dose-ranging ... [Published Individual.com - Mar 24 2014]
First reported Mar 24 2014 - Updated Mar 24 2014 - 1 reports

The Scar Solution Review | Discover A Newly Updated Scar Treatment Method - Vkool.com

Since Sean Lowry released “The Scar Solution” program, many people have used it to find the best way to get rid of their ugly facial scarring.[...] Kenn Paquette from the site Vkool.com performed a full review of The Scar Solution program that points ... [Published MySanAntonio - Mar 24 2014]
First reported Mar 22 2014 - Updated Mar 22 2014 - 1 reports

Novan announces positive Phase 2 results for novel acne treatment

DURHAM, N.C.--Novan Therapeutics, a specialty pharmaceutical company focused on advancing nitric oxide therapies for a number of diseases, announced today positive Phase 2 study results of its topical SB204 drug candidate for the treatment of acne vulgaris. ... [Published Drug Discovery News - Mar 22 2014]
First reported Mar 19 2014 - Updated Mar 19 2014 - 1 reports

Durham's Novan shows positive trial results on acne treatment

Durham drug developer Novan Therapeutics announced positive results from studies to test its drug’s potential as an acne treatment.The study showed that those who received the Novan treatment, called SB204 for now, showed benefits three times faster than ... [Published Triangle Business Journal - Mar 19 2014]
First reported Mar 19 2014 - Updated Mar 19 2014 - 2 reports

Novan Therapeutics reports positive results from SB204 Phase 2 study for treatment of acne vulgaris

Novan Therapeutics, a specialty pharmaceutical company focused on advancing nitric oxide therapies for a number of diseases, announced today positive Phase 2 study results of its topical SB204 drug candidate for the treatment of acne vulgaris. Acne is ... [Published News-Medical.Net - Mar 19 2014]
First reported Mar 12 2014 - Updated Mar 12 2014 - 1 reports

Knowing The Best Face Wash For Acne For Every Type Of Skin

A number of people are struggling with acne vulgaris on their faces. The age group that frequently affected are the young adults since this is when their oil glands become active. The sebaceous glands produce oil which is commanded by the hormones thRidgeland ... [Published I-Newswire - Mar 12 2014]
First reported Feb 06 2014 - Updated Feb 06 2014 - 1 reports

USPTO issues patent to Elorac for novel acne therapy

Elorac, a specialty pharmaceutical company focused on the treatment of dermatological disorders, announced that the US Patent and Trademark Office (USPTO) has issued US patent No. 8,604,047 entitled ‘Method and Composition for Treating Nodulocystic and ... [Published Pharmaceutical Business Review - Feb 06 2014]

Quotes

"Free drug samples can alter the prescribing habits of physicians away from the use of less expensive generic medications. The benefits of free samples in dermatology must be weighed against potential negative effects on prescribing behavior and prescription costs."
In a related editorial, Kenneth A Katz, M D , M Sc., of the Permanente Medical Group Inc., Pleasanton, Calif., and colleagues write: "The study was cross-sectional and did not determine causality, and no clinical outcomes were assessed. But the demonstrated association between samples and prescribing is strong and is consistent with a growing body of evidence that drug samples affect physician prescribing practices."
Commenting on the new financing, Elite's President and CEO, Mr. Nasrat HakimHakim said, "This commitment from Lincoln Park helps Elite to develop our range of abuse resistant opioids on an accelerated pace. By investing in the clinical development of our abuse deterrent products, we expect to significantly increase the value of these products in anticipation of future product partnerships. There is a great interest in our technology and, as Elite has done since I started here last August, we will continue to aggressively scale up and complete the clinical studies necessary to file these products as soon as possible. Our first filing is expected to be by year's end."
...on the body and swiftly eliminates excess fat with remarkable instant results," said Pete McGuinness, Chief Executive Officer of Chromogenex. "This unique combination of laser technology is a huge breakthrough in aesthetics, and we see i-LipoXcell as being very unique to the marketplace."

More Content

All (34) | News (32) | Reports (0) | Blogs (1) | Audio/Video (0) | Fact Sheets (0) | Press Releases (1)
sort by: Date | Relevance
Free medication samples in dermatology offices ... [Published News-Medical.Net - 15 hours ago]
Free samples of prescription drugs are costly t... [Published Los Angeles Times - 20 hours ago]
Free drug samples can change prescribing habits... [Published EurekAlert! - 23 hours ago]
Elite Pharmaceuticals to Receive up to 40 Milli... [Published Accesswire - Apr 15 2014]
IV azithromycin and Eviplera among medicines ap... [Published PJ Online - Apr 08 2014]
Chromogenex Announces Third Generation Body Sha... [Published GTN News - Apr 07 2014]
Chromogenex Announces Third Generation Body Sha... [Published KSWO - Apr 07 2014]
Researchers Submit Patent Application, "Composi... [Published 4 Traders - Apr 02 2014]
What you should know about acne [Published Manila Standard Today - Apr 02 2014]
The effects of oral isotretinoin (13-Cis retino... [Published Clinical & Investigative Medicine - Apr 01 2014]
Lorde Reveals Acne To Prove ‘Flaws Are Ok’ [Published Business 2 Community - Apr 01 2014]
Novan Announces Positive Phase 2 Results for No... [Published MedEsthetics Magazine - Mar 28 2014]
GLENMARK PHARMACEUTICALS : Patent Issued for St... [Published 4 Traders - Mar 27 2014]
Novan Therapeutics announces positive results f... [Published Individual.com - Mar 24 2014]
Novan Releases Positive Phase 2 Results for Nov... [Published Pharmacy Choice - Mar 24 2014]
The Scar Solution Review | Discover A Newly Upd... [Published MySanAntonio - Mar 24 2014]
Novan announces positive Phase 2 results for no... [Published Drug Discovery News - Mar 22 2014]
Elevated Social Stress Levels and Depressive Sy... [Published PLoS medicine - Mar 19 2014]
Durham's Novan shows positive trial results on ... [Published Triangle Business Journal - Mar 19 2014]
Novan Therapeutics reports positive results fro... [Published News-Medical.Net - Mar 19 2014]
Novan Announces Positive Phase 2 Results for No... [Published Business Wire Health News - Mar 19 2014]
A calling to help those less fortunate [Published MyPaper.sg - Mar 17 2014]
The surprising reason Americans might be obese,... [Published Sott.net - Mar 12 2014]
Researchers Submit Patent Application, "Anti-An... [Published 4 Traders - Mar 12 2014]
Knowing The Best Face Wash For Acne For Every T... [Published I-Newswire - Mar 12 2014]
USPTO issues patent to Elorac for novel acne th... [Published Pharmaceutical Business Review - Feb 06 2014]
US FDA approves Valeant Pharma's Retin-A Micro ... [Published PharmaBiz - Feb 03 2014]
From ‘Pit Senyor!’ to ‘Kung Hei Fat Choy!’ [Published Philippine Daily Inquirer - Feb 01 2014]
Valeant receives FDA approval for Retin-A Micro [Published Stockwatch - Jan 31 2014]
Acne Free In 3 Days Review – How This Program H... [Published PRWeb - Jan 03 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Novan Announces Positive Phase 2 Results for No... [Published Business Wire Health News - Mar 19 2014]
DURHAM, N.C.--(BUSINESS WIRE)--Novan Therapeutics, a specialty pharmaceutical company focused on advancing nitric oxide therapies for a number of diseases, announced today positive Phase 2 study results of its topical SB204 drug candidate for the treatment ...
1

Press Releases

sort by: Date | Relevance
Medicis Announces Winners of First Annual I Aca... [Published PR Newswire - Sep 26 2013]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.